(Q42990186)

12 November 2017

High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C. (English)

1 reference

12 November 2017

1 reference

1 reference

11

1 reference

12 November 2017

10

Houghton M

1 reference

12 November 2017

Ishii K

1

1 reference

12 November 2017

Rosa D

2

1 reference

12 November 2017

Watanabe Y

3

1 reference

12 November 2017

Katayama T

4

1 reference

12 November 2017

Harada H

5

1 reference

12 November 2017

Wyatt C

6

1 reference

12 November 2017

Kiyosawa K

7

1 reference

12 November 2017

Aizaki H

8

1 reference

12 November 2017

Matsuura Y

9

1 reference

12 November 2017

Miyamura T

12

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 October 1998

1 reference

12 November 2017

1 reference

12 November 2017

28

1 reference

12 November 2017

1117-1120

1 reference

12 November 2017

4

1 reference

Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis

12 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280429

7 January 2021

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280429

7 January 2021

Hepatitis C virus infection is associated with the development of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280429

7 January 2021

Efficacy of prophylactic gamma-globulin in preventing non-A, non-B post-transfusion hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280429

7 January 2021

Prevention of post-transfusion non-A, non-B hepatitis by non-specific immunoglobulin in heart surgery patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280429

7 January 2021

Effect of immune globulin on the prevention of experimental hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280429

7 January 2021

Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280429

7 January 2021

Vaccination of chimpanzees against infection by the hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280429

7 January 2021

A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280429

7 January 2021

A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280429

7 January 2021

Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: application to diagnosis and blood screening for posttransfusion hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280429

7 January 2021

Serodiagnosis of hepatitis C virus (HCV) infection with an HCV core protein molecularly expressed by a recombinant baculovirus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280429

7 January 2021

Expression of processed envelope protein of hepatitis C virus in mammalian and insect cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280429

7 January 2021

Establishment of a cell line constitutively expressing E2 glycoprotein of hepatitis C virus and humoral response of hepatitis C patients to the expressed protein

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280429

7 January 2021

Induction of antibodies against structural proteins of hepatitis C virus in mice using recombinant adenovirus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280429

7 January 2021

Mother-to-child transmission of a hepatitis C virus variant with an insertional mutation in its hypervariable region

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280429

7 January 2021

Serial assay of hepatitis C virus RNA in serum for predicting response to interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280429

7 January 2021

Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280429

7 January 2021

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280429

7 January 2021

T-lymphocyte response to hepatitis C virus in different clinical courses of infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280429

7 January 2021

Identifiers

DOI

10.1002/HEP.510280429

1 reference

12 November 2017

1 reference